Wellcome uses cookies.

Read our policy
Skip to main content
6 results filtered with: Melanoma - drug therapy
  • 'Alkeran' for the treatment of multiple myeloma, malignant melanoma, and certain other malignant conditions / Burroughs Wellcome & Co. (the Wellcome Foundation Ltd.).
  • 'Alkeran' for the treatment of multiple myeloma, malignant melanoma, and certain other malignant conditions / Burroughs Wellcome & Co. (the Wellcome Foundation Ltd.).
  • 'Alkeran' for the treatment of multiple myeloma, malignant melanoma, and certain other malignant conditions / Burroughs Wellcome & Co. (the Wellcome Foundation Ltd.).
  • 'Alkeran' for the treatment of multiple myeloma, malignant melanoma, and certain other malignant conditions / Burroughs Wellcome & Co. (the Wellcome Foundation Ltd.).
  • 'Alkeran' for the treatment of multiple myeloma, malignant melanoma, and certain other malignant conditions / Burroughs Wellcome & Co. (the Wellcome Foundation Ltd.).
  • 'Alkeran' for the treatment of multiple myeloma, malignant melanoma, and certain other malignant conditions / Burroughs Wellcome & Co. (the Wellcome Foundation Ltd.).